Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Ranibizumab for NV-AMD
Glaucoma device controls IOP
Illumination for poor red reflex
Photoscreeners for anismentropia
 
 
Survey

Would you use ranibizumab for neovascular AMD?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


July 24, 2013
Ranibizumab passes first safety profile for NV-AMD
Ranibizumab has passed the one-year safety profile for neovascular age-related macular degeneration (NV-AMD), claims a recent paper. More...
Glaucoma device controls IOP in high-risk PK
The Ahmed glaucoma device (AGD) effectively controls intraocular pressure (IOP) with high-risk penetrating keratoplasty, reveal the findings from a study in the journal Cornea. More...
Illumination provides clear imaging for poor red reflex eyes
Intracameral illumination provides high-quality imaging and near 360° lens capsule structure visualization in eyes with poor red reflex, states a recent paper. More...
Photoscreeners detect anismentropia
A recent study in the Journal of Paediatric Ophthalmology & Strabismus states that objective photoscreeners are valid for the detection of contact lens-induced anisometropia. More...


Product Profiles
Coherent, Inc
Excimer lasers have revolutionized eye surgery. Myopia, astigmatism, and hyperopia are treated fast and effectively with precisely controllable UV laser energy. Coherent is the undisputed leader in LASIK excimer lasers. Read More